Personal information

Countries

United States

Activities

Collapse all

Employment (1)

Beth Israel Deaconess Medical Center: Boston, MA, US

2019-08-01 to 2020-10-16 (Gastroenterology)
Employment
Source: Self-asserted source
William Clarke

Education and qualifications (5)

Beth Israel Deaconess Medical Center: Boston, MA, US

2016-07-01 to 2019-06-30 | Clinical Fellow (Gastroenterology)
Education
Source: Self-asserted source
William Clarke

UCSF Medical Center: San Francisco, CA, US

2013-07-01 to 2016-06-30 | Resident (Internal Medicine)
Education
Source: Self-asserted source
William Clarke

Yale University School of Medicine: New Haven, CT, US

2009-09-01 to 2013-05-31 | MD
Education
Source: Self-asserted source
William Clarke

University of Oxford: Oxford, Oxfordshire, GB

2007-09-01 to 2009-05-31 | MSc (Physiology, Anatomy and Genetics)
Education
Source: Self-asserted source
William Clarke

University of California Los Angeles: Los Angeles, CA, US

2003-09 to 2007-06 | BS (Molectular, Cell and Developmental Biology)
Education
Source: Self-asserted source
William Clarke

Works (14)

Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay.

Journal of clinical medicine
2020-09-02 | Journal article
DOI: 10.3390/jcm9092840
PMID: 32887317
PMC: PMC7565738
Source: Self-asserted source
William Clarke
grade
Preferred source (of 2)‎

Antibiotic prophylaxis and infectious complications in patients on peritoneal dialysis undergoing lower gastrointestinal endoscopy.

Gastroenterology report
2020-04-25 | Journal article
DOI: 10.1093/gastro/goaa017
PMID: 33163197
PMC: PMC7603873
Source: Self-asserted source
William Clarke

Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
2020-03-05 | Journal article
DOI: 10.1016/j.cgh.2020.03.002
PMID: 32147594
Source: Self-asserted source
William Clarke

Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study.

Inflammatory bowel diseases
2019-09-27 | Journal article
DOI: 10.1093/ibd/izz202
PMID: 31559417
Source: Self-asserted source
William Clarke

Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.

World Journal of Gastroenterology
2019-08-01 | Journal article
DOI: 10.3748/wjg.v25.i30.4148
PMID: 31435169
PMC: PMC6700690
Source: Self-asserted source
William Clarke

Editorial: older patients are significantly more likely to have colon ischaemia-associated conditions that are chronic and complex.

Alimentary pharmacology & therapeutics
2019-08-01 | Journal article
DOI: 10.1111/apt.15287
PMID: 31313367
Source: Self-asserted source
William Clarke

Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B.

Journal of viral hepatitis
2019-05-28 | Journal article
DOI: 10.1111/jvh.13147
PMID: 31134715
Source: Self-asserted source
William Clarke

After surgery for stage II or III colorectal cancer, more vs less frequent follow-up did not differ for 5-year mortality.

Annals of internal medicine
2018-10 | Journal article
DOI: 10.7326/acpjc-2018-169-8-038
PMID: 30326082
Contributors: Clarke WT; Feuerstein JD
Source: Self-asserted source
William Clarke via Europe PubMed Central

Updates in colorectal cancer screening in inflammatory bowel disease.

Current opinion in gastroenterology
2018-07 | Journal article
DOI: 10.1097/mog.0000000000000448
PMID: 29771698
Contributors: Clarke WT; Feuerstein JD
Source: Self-asserted source
William Clarke via Europe PubMed Central

Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAg-) on anti-TNF therapy have a low rate of reactivation.

Clinical immunology (Orlando, Fla.)
2018-03 | Journal article
DOI: 10.1016/j.clim.2018.03.013
PMID: 29601854
Contributors: Clarke WT; Amin SS; Papamichael K; Feuerstein JD; Cheifetz AS
Source: Self-asserted source
William Clarke via Europe PubMed Central

Gemtuzumab ozogamicin: is there room for salvage?

Blood
2010-10 | Journal article
DOI: 10.1182/blood-2010-08-300871
PMID: 20930085
Contributors: Clarke WT; Marks PW
Source: Self-asserted source
William Clarke via Europe PubMed Central

Syncoilin modulates peripherin filament networks and is necessary for large-calibre motor neurons.

Journal of cell science
2010-06 | Journal article
DOI: 10.1242/jcs.059113
PMID: 20587592
PMC: PMC2908046
Contributors: Clarke WT; Edwards B; McCullagh KJ; Kemp MW; Moorwood C; Sherman DL; Burgess M; Davies KE
Source: Self-asserted source
William Clarke via Europe PubMed Central

Syncoilin isoform organization and differential expression in murine striated muscle.

Journal of structural biology
2008-12 | Journal article
DOI: 10.1016/j.jsb.2008.11.002
PMID: 19070665
Contributors: Kemp MW; Edwards B; Burgess M; Clarke WT; Nicholson G; Parry DA; Davies KE
Source: Self-asserted source
William Clarke via Europe PubMed Central

Direct interaction of Gas11 with microtubules: implications for the dynein regulatory complex.

Cell motility and the cytoskeleton
2007-06 | Journal article
DOI: 10.1002/cm.20196
PMID: 17366626
Contributors: Bekker JM; Colantonio JR; Stephens AD; Clarke WT; King SJ; Hill KL; Crosbie RH
Source: Self-asserted source
William Clarke via Europe PubMed Central

Peer review (3 reviews for 1 publication/grant)

Review activity for Digestive diseases and sciences. (3)
How many people are using ORCID?